ALLMedicine™ Hyperhidrosis Center

Mar 24th, 2023 - Microwave therapy is used to treat axillary hyperhidrosis and osmidrosis. Even while a "danger zone" has been identified and reports of potential complications from nerve injury have been made, there has been little real-world discussion regarding...

Mar 24th, 2023 - Auvelity, an extended-release fixed combination of dextromethorphan and bupropion, is approved for the treatment of major depressive disorder in adults.Like all antidepressants, dextromethorphan-bupropion carries a boxed warning that it may increa...

Mar 21st, 2023 - Hyperhidrosis has a significant impact on a person’s physical, psychological, and social aspects of life. The lack of treatment options and associated stigma limits access to care and treatment options.

Mar 21st, 2023 - History The three clinical stages of type 1 complex regional pain syndrome (CRPS 1) are acute, subacute, and chronic. The acute form lasts approximately 3 months. Pain, often burning in nature, is one of the first symptoms that initially limits fu...

Mar 21st, 2023 - Practice Essentials Type 1 complex regional pain syndrome (CRPS 1), formerly known as reflex sympathetic dystrophy (RSD), is a clinical syndrome of variable course and unknown cause characterized by pain, swelling, and vasomotor dysfunction of an ...

Feb 21st, 2023 - Interruption of intrathoracic sympathetic neural pathway surgically to treat hyperhidrosis by using video - thoracoscopy which has lead to explosion of minimally invasive technique for this issue. It's safe procedure and success rate in about 95% ...

Jan 26th, 2023 - In 2016, there were an estimated 15.5 million cancer survivors in the US, with a forecasted 20.3 million by 2026. Three percent of those survivors were treated for Head and neck cancers (HNC). This number is expected to rise due to increased long-...

Jan 13th, 2023 - This trial aims is to assess and compare treatment effect of microwave thermolysis and botulinum toxin A for axillary hyperhidrosis with focus on longevity. The investigators also aim to assess patient satisfaction and adverse reactions in relatio...

Jan 6th, 2023 - This is a randomized, open-label, phase 3 long-term study designed to evaluate the safety, local tolerability and efficacy of sofpironium bromide gel when applied topically to the axillae. Subjects will apply the gel once daily at bedtime, to both...

Dec 28th, 2022 - This is a multicenter, randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of topically applied sofpironium bromide, 15% gel in subjects with axillary hyperhidrosis. Safety will be assessed through collection of ...

Mar 21st, 2023 - Hyperhidrosis has a significant impact on a person’s physical, psychological, and social aspects of life. The lack of treatment options and associated stigma limits access to care and treatment options.

Mar 19th, 2023 - NEW ORLEANS – Application of a single-use disposable patch to the axillary area for up to 3 minutes led to statistically significant and clinically meaningful benefit for patients with primary axillary hyperhidrosis, results from a pivotal randomi.

Feb 27th, 2023 - Experts shared advice on diagnosis and treatment of children and adolescents showing signs of post-COVID conditions -- also known as long COVID -- during a CDC Clinician Outreach and Communication Activity (COCA) webinar. "Post-COVID conditions" i...

Dec 20th, 2022 - To the Editor: Complex regional pain syndrome (CRPS) is a neurologic condition characterized by chronic pain and sensory changes, including allodynia and hyperalgesia, that usually affect the extremities. 1,2 The syndrome is defined by the Internat.

Nov 16th, 2022 - The terms Microtox, MicroBotox, Mesotox, and MesoBotox have been thrown around in the dermatology literature, clinical medicine, and the media, leaving patients confused about what they treat and physicians confused about what patients want when t.